Cellyan Biotechnology Co., Ltd (HKPD) has a market capitalization of $7.63M and trades at $0.69. The 52-week range is 0.37-2.76.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -257.4, Earnings Per Share (EPS) of $0.00, annual revenue of $20.31M.
The stock has a beta of 3.80, operates in the Healthcare sector.
